PI3K pathway as a major determinant of resistance to HER2-targeted therapy in advanced gastric cancer

被引:0
|
作者
Kim, Hyo Song
Zhang, Xianglan
Park, Kyu Hyun
Park, Ji Soo
Kim, Ki Hyang
Chung, Hyun Cheol
Rha, Sun Young
机构
[1] Yonsei Univ Coll Med, Dept Internal Med, Seoul, South Korea
[2] Yonsei Univ Coll Dent, Oral Canc Res Inst, Seoul, South Korea
[3] Yonsei Univ Coll Med, Canc Metastasis Res Ctr, Seoul, South Korea
[4] Yonsei Univ Coll Med, Div Med Oncol, Dept Internal Med, Yonsei Canc Ctr, Seoul, South Korea
[5] Inje Univ Coll Med, Busan Paik Hosp, Div Hematol Oncol, Dept Internal Med, Pusan, South Korea
[6] Yonsei Univ Heath Syst, Yonsei Canc Ctr, Seoul, South Korea
[7] Yonsei Univ Coll Med, Yonsei Canc Ctr, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
4089
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Analysis of PIK3CA mutations and PI3K pathway proteins in advanced gastric cancer
    Ito, Chie
    Nishizuka, Satoshi S.
    Ishida, Kazuyuki
    Uesugi, Noriyuki
    Sugai, Tamotsu
    Tamura, Gen
    Koeda, Keisuke
    Sasaki, Akira
    JOURNAL OF SURGICAL RESEARCH, 2017, 212 : 195 - 204
  • [42] Evolving Strategies for Overcoming Resistance to HER2-Directed Therapy: Targeting the PI3K/Akt/mTOR Pathway
    Nahta, Rita
    O'Regan, Ruth M.
    CLINICAL BREAST CANCER, 2010, 10 : S72 - S78
  • [43] Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
    Toomey, Sinead
    Eustace, Alexander J.
    Fay, Joanna
    Sheehan, Katherine M.
    Carr, Aoife
    Milewska, Malgorzata
    Madden, Stephen F.
    Teiserskiene, Ausra
    Kay, Elaine W.
    O'Donovan, Norma
    Gallagher, William
    Grogan, Liam
    Breathnach, Oscar
    Walshe, Janice
    Kelly, Catherine
    Moulton, Brian
    Kennedy, M. John
    Gullo, Guiseppe
    Hill, Arnold D.
    Power, Colm
    Duke, Deirdre
    Hambly, Niamh
    Crown, John
    Hennessy, Bryan T.
    BREAST CANCER RESEARCH, 2017, 19
  • [44] PI3K inhibitors in trastuzumab-resistant HER2-positive breast cancer cells with PI3K pathway alterations
    Chung, Wei-Pang
    Huang, Wei-Lun
    Lee, Chun-Hui
    Hsu, Hui-Ping
    Huang, Wan-Ling
    Liu, You-Yu
    Su, Wu-Chou
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (07): : 3067 - +
  • [45] HER2 Testing and Targeted Therapy in Advanced Gastric Cancer
    Hoehler, Thomas
    Rueschoff, Josef
    Ridwelski, Karsten
    Moehler, Markus
    ONKOLOGIE, 2010, 33 : 26 - 30
  • [46] Impact of somatic PI3K pathway and ERBB family mutations on pathological complete response (pCR) in HER2-positive breast cancer patients who received neoadjuvant HER2-targeted therapies
    Sinead Toomey
    Alexander J. Eustace
    Joanna Fay
    Katherine M. Sheehan
    Aoife Carr
    Malgorzata Milewska
    Stephen F. Madden
    Ausra Teiserskiene
    Elaine W. Kay
    Norma O’Donovan
    William Gallagher
    Liam Grogan
    Oscar Breathnach
    Janice Walshe
    Catherine Kelly
    Brian Moulton
    M. John Kennedy
    Guiseppe Gullo
    Arnold D. Hill
    Colm Power
    Deirdre Duke
    Niamh Hambly
    John Crown
    Bryan T. Hennessy
    Breast Cancer Research, 19
  • [47] HER2-targeted therapy in colorectal cancer: a comprehensive review
    Benli, Yeliz
    Arikan, Helin
    Akbulut-caliskan, Ozge
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2025,
  • [48] HOTAIR Silencing Reduces Oxaliplatin Resistance in Gastric Cancer through PI3K/Akt Pathway
    Sun, Xiaohui
    Shi, Yuyan
    Hua, Nan
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2022, 36 (06): : 1773 - 1780
  • [49] Late cardiotoxicity related to HER2-targeted cancer therapy
    Isabelle Senechal
    Maria Sol Andres
    Jieli Tong
    Ylenia Perone
    Sivatharshini Ramalingam
    Muhummad Sohaib Nazir
    Stuart D Rosen
    Nicholas Turner
    Alistair Ring
    Alexander R Lyon
    Cardio-Oncology, 10
  • [50] Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer
    Meric-Bernstam, Funda
    Johnson, Amber M.
    Dumbrava, Ecaterina E. Ileana
    Raghav, Kanwal
    Balaji, Kavitha
    Bhatt, Michelle
    Murthy, Rashmi K.
    Rodon, Jordi
    Piha-Paul, Sarina A.
    CLINICAL CANCER RESEARCH, 2019, 25 (07) : 2033 - 2041